Maroney Dawn Christine 4
4 · Alignment Healthcare, Inc. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Alignment Healthcare (ALHC) President Dawn Maroney Receives Award, Sells Shares
What Happened
Dawn Christine Maroney, President of Alignment Healthcare (ALHC), was granted 161,860 restricted stock units (RSUs) on 2026-03-13 and sold 30,000 shares in an open-market transaction on 2026-03-16 for a reported total of $524,427 (weighted-average price $17.48). The RSUs were granted at no cash cost to the reporting person and will convert to shares as they vest.
Key Details
- Grant: 161,860 RSUs granted on 2026-03-13 (each RSU = right to one share). Grant has vesting roughly one-third on each of the first three anniversaries of the grant date (Footnote F1).
- Sale: 30,000 shares sold on 2026-03-16; weighted-average sale price $17.48; total proceeds reported $524,427. Per-footnote, individual trade prices ranged $17.12–$17.60 (Footnote F3).
- 10b5-1 plan: Sale was made under a Rule 10b5-1 plan adopted 05/22/2025 (Footnote F2).
- Shares owned after transaction: Not specified on this Form 4.
- Filing timeliness: No late filing indicated in the report.
Context
RSU grants are compensation awards that vest over time and do not reflect an immediate cash purchase; they become shares if and when they vest. The sale was executed under a pre-established 10b5-1 trading plan, which is a common mechanism executives use to sell shares on a predetermined schedule and does not necessarily signal current management view.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-13+161,860→ 1,125,562 total - Sale
Common Stock
[F2][F3]2026-03-16$17.48/sh−30,000$524,427→ 1,095,562 total
Footnotes (3)
- [F1]Represents 161,860 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.
- [F2]Date of Rule 10b5-1 plan adoption: 05/22/2025
- [F3]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.12 to $17.60. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.